Did Thomas Tuberville sell Regeneron Pharmaceuticals stock?
Republican · U.S. Senate · Alabama
Latest filing May 15, 2024
Yes. Thomas Tuberville disclosed 1 sale of Regeneron Pharmaceuticals (REGN) stock on Apr 4, 2024, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.
Every Regeneron Pharmaceuticals trade
Thomas Tuberville trades in Regeneron Pharmaceuticals
Did Thomas Tuberville sell Regeneron Pharmaceuticals stock?
Yes. Thomas Tuberville disclosed 1 sale of Regeneron Pharmaceuticals (REGN) stock on Apr 4, 2024, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.
How big were Thomas Tuberville's Regeneron Pharmaceuticals trades?
STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $1K-$15K.
Did Thomas Tuberville make these Regeneron Pharmaceuticals trades personally?
Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.
Does Thomas Tuberville still own Regeneron Pharmaceuticals stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did Thomas Tuberville report these trades?
The latest filing is dated May 15, 2024. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.
Loading